|
1
|
Shin HR, Carlos MC and Varghese C: Cancer
control in the Asia Pacific region: current status and concerns.
Jpn J Clin Oncol. 42:867–881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Bonomi M, Pilotto S, Milella M, Massari F,
Cingarlini S, Brunelli M, Chilosi M, Tortora G and Bria E: Adjuvant
chemotherapy for resected non-small-cell lung cancer: future
perspectives for clinical research. J Exp Clin Cancer Res.
30:1152011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang P, Enomoto A, Jijiwa M, Kato T,
Hasegawa T, Ishida M, Sato T, Asai N, Murakumo Y and Takahashi M:
An actin-binding protein Girdin regulates the motility of breast
cancer cells. Cancer Res. 68:1310–1318. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garcia-Marcos M, Jung BH, Ear J, Cabrera
B, Carethers JM and Ghosh P: Expression of GIV/Girdin, a
metastasis-related protein, predicts patient survival in colon
cancer. FASEB J. 25:590–599. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Natsume A, Kato T, Kinjo S, Enomoto A,
Toda H, Shimato S, Ohka F, Motomura K, Kondo Y, et al: Girdin
maintains the stemness of glioblastoma stem cells. Oncogene.
31:2715–2724. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu C, Zhang Y, Xu H, Zhang R, Li H, Lu P
and Jin F: Girdin protein: a new potential distant metastasis
predictor of breast cancer. Med Oncol. 29:1554–1560. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ling Y, Jiang P, Cui SP, Ren YL, Zhu SN,
Yang JP, Du J, Zhang Y, Liu JY and Zhang B: Clinical implications
for girdin protein expression in breast cancer. Cancer Invest.
29:405–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu C, Xue H, Lu Y and Chi B: Stem cell
gene Girdin: a potential early liver metastasis predictor of
colorectal cancer. Mol Biol Rep. 39:8717–8722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jun BY, Kim SW, Jung CK, Cho YK, Lee IS,
Choi MG, Choi KY and Oh ST: Expression of girdin in human
colorectal cancer and its association with tumor progression. Dis
Colon Rectum. 56:51–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ghosh P, Garcia-Marcos M and Farquhar MG:
GIV/Girdin is a rheostat that fine-tunes growth factor signals
during tumor progression. Cell Adh Migr. 5:237–248. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weng L, Enomoto A, Ishida-Takagishi M,
Asai N and Takahashi M: Girding for migratory cues: roles of the
Akt substrate Girdin in cancer progression and angiogenesis. Cancer
Sci. 101:836–842. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghosh P, Beas AO, Bornheimer SJ,
Garcia-Marcos M, Forry EP, Johannson C, Ear J, Jung BH, Cabrera B,
Carethers JM and Farquhar MG: A Gαi-GIV molecular complex binds
epidermal growth factor receptor and determines whether cells
migrate or proliferate. Mol Biol Cell. 21:2338–2354. 2010.
|
|
14
|
Enomoto A, Murakami H, Asai N, Morone N,
Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K and
Takahashi M: Akt/PKB regulates actin organization and cell motility
via Girdin/APE. Dev Cell. 9:389–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kitamura T, Asai N, Enomoto A, Maeda K,
Kato T, Ishida M, Jiang P, Watanabe T, Usukura J, et al: Regulation
of VEGF-mediated angiogenesis by the Akt/PKB substrate Girdin. Nat
Cell Biol. 10:329–337. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brambilla E, Travis WD, Colby TV, Corrin B
and Shimosato Y: The new World Health Organization classification
of lung tumours. Eur Respir J. 18:1059–1068. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ohara K, Enomoto A, Kato T, Hashimoto T,
Isotani-Sakakibara M, Asai N, Ishida-Takagishi M, Weng L, Nakayama
M, et al: Involvement of Girdin in the determination of cell
polarity during cell migration. PLoS One. 7:e366812012. View Article : Google Scholar
|
